This document is an addendum to the guideline on clinical investigation of medicinal products in the treatment of hypertension. It highlights differences from adult patients with arterial hypertension and points out paediatric-specific aspects.
Keywords: Paediatric, drug evaluation, drug approval guideline, hypertension, clinical evaluation, efficacy criteria, safety aspects
Current effective version
Paediatric addendum to the note for guidance on the clinical investigation on medicinal products in the treatment of hypertension
This is an addendum to the Guideline on Clinical Investigation of Medicinal Products in the Treatment of Hypertension (EMA/238/1995/Rev. 3, 18 November 2010). It is not meant as a guidance document on its own but rather highlights differences from adult patients with arterial hypertension and points out paediatric-specific aspects.
English (EN) (190.51 KB - PDF)
Document history - First version (current)
Paediatric addendum to the note for guidance on the clinical investigation on medicinal products in the treatment of hypertension
This is an addendum to the Guideline on Clinical Investigation of Medicinal Products in the Treatment of Hypertension (EMA/238/1995/Rev. 3, 18 November 2010). It is not meant as a guidance document on its own but rather highlights differences from adult patients with arterial hypertension and points out paediatric-specific aspects.
English (EN) (190.51 KB - PDF)
Overview of comments received on 'Paediatric addendum to the note for guidance on the clinical investigation on medicinal products in the treatment of hypertension'
English (EN) (134.84 KB - PDF)
Draft paediatric addendum to the note for guidance on the clinical investigation on medicinal products in the treatment of hypertension
This is an addendum to the guideline on clinical investigation of medicinal products in the treatment of hypertension (EMA/238/1995/Rev. 3, 18 November 2010). It is not meant as a guidance document on its own but rather highlights differences from adult patients with arterial hypertension and points out paediatric-specific aspects.
English (EN) (195.75 KB - PDF)
Concept paper on the need for the development of a paediatric addendum to the note for guidance on the clinical investigation on medicinal products in the treatment of hypertension
English (EN) (97.83 KB - PDF)
Related content
- Clinical efficacy and safety: cardiovascular system
- Scientific guidelines: paediatrics
- Clinical investigation on medicinal products in the treatment of hypertension
- Clinical trials in small populations
- ICH E11 Clinical investigation of medicinal products in the paediatric population
- Impact of renal immaturity when investigating medicinal products intended for paediatric use
- Pharmaceutical development of medicines for paediatric use
- Role of pharmacokinetics in the development of medicinal products in the paediatric population